Article info

Medication practice in hospitals: are nanosimilars evaluated and substituted correctly?

Authors

  1. Correspondence to Dr Beat Flühmann, Vifor Pharma Ltd, Flughofstrasse 61, Glattbrugg 8152, Switzerland; beat.fluehmann{at}viforpharma.com
View Full Text

Citation

Knoeff J, Flühmann B, Mühlebach S
Medication practice in hospitals: are nanosimilars evaluated and substituted correctly?

Publication history

  • Received July 21, 2016
  • Revised October 26, 2016
  • Accepted December 20, 2016
  • First published January 23, 2017.
Online issue publication 
February 22, 2018

Article Versions

  • This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.